U.S. Supreme Court asks for views on 'skinny label' case

Alexion, the rare disease division of AstraZeneca, will pay about $70 million to buy a small gene therapy company called LogicBio.

Related Keywords

,Glaxosmithkline ,Us Supreme Court ,Drug Administration ,Reuters ,Teva Pharmaceuticals ,Morning Mayor ,